Who owns ACELRX PHARMACEUTICALS INC?
- Ticker: TLPH
- CUSIP Number: 00444t209
Tip: Access positions for across all investors
Analyze quarterly positions in Acelrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Acelrx Pharmaceuticals stock
Who bought or sold ACELRX PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Nantahala Capital Management | 2.0M | $1.7M | 0% | Sep 2024 |
|
Rosalind Advisors | 759k | $650k | 0% | Sep 2024 |
|
Rock Springs Capital Management | 317k | $282k | 0% | Jun 2024 |
|
MAI Wealth Advisors | 282k | $242k | -1% | Sep 2024 |
|
Vanguard Group | 241k | $215k | 36% | Jun 2024 |
|
Geode Capital Management | 156k | $133k | 9% | Sep 2024 |
|
Values First Advisors | 111k | $95k | -2% | Sep 2024 |
|
Susquehanna International | 97k | $83k | 24% | Sep 2024 |
|
BlackRock | 92k | $78k | 100% | Sep 2024 |
|
BlackRock | 92k | $82k | 0% | Jun 2024 |
|
Royal Bank of Canada | 85k | $73k | -57% | Sep 2024 |
|
Two Sigma Securities | 39k | $35k | 100% | Jun 2024 |
|
State Street Corporation | 22k | $20k | 0% | Jun 2024 |
|
United Bank | 15k | $13k | 0% | Sep 2024 |
|
Northern Trust | 11k | $9.3k | 0% | Sep 2024 |
|
Tower Research Capital | 7.8k | $7.0k | -3% | Jun 2024 |
|
Sterling Capital Management | 2.0k | $1.7k | 100% | Sep 2024 |
|
Group One Trading | 1.7k | $1.5k | 0% | Sep 2024 |
|
Morgan Stanley | 1.2k | $1.0k | -88% | Jun 2024 |
|
Wells Fargo & Company | 758.00 | $648.999600 | -2% | Sep 2024 |
|
Goss Wealth Management | 500.00 | $445.000000 | 0% | Jun 2024 |
|
CoreCap Advisors | 500.00 | $428.000000 | -72% | Sep 2024 |
|
Advisor Group Holdings | 313.00 | $266.989000 | -76% | Sep 2024 |
|
Bank of America Corporation | 180.00 | $154.278000 | 29% | Sep 2024 |
|
Jpmorgan Chase & Co | 141.00 | $121.006200 | 236% | Sep 2024 |
|
Silicon Valley Capital Partners | 137.00 | $116.998000 | 0% | Sep 2024 |
|
Global Retirement Partners | 73.00 | $62.999000 | 0% | Sep 2024 |
|
Absolute Investment Management | 50.00 | $43.000000 | 0% | Sep 2024 |
|
Barclays | 11.00 | $0 | 100% | Sep 2024 |
|
Qube Research & Technologies | 1.00 | $1.000000 | 0% | Jun 2024 |
|
Who sold out of Acelrx Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Turtle Creek Wealth Advisors | Jun 2024 | 72k | $64k |
Citadel Advisors | Jun 2024 | 36k | $32k |
Simplex Trading | Jun 2024 | 9.00 | $0 |